Cormorant Capital
Overview
Cormorant Capital is a real estate investment firm that facilitates the growth of real estate owner clients by sourcing equity solutions and co-investing in select transactions, with a focus on value-add and opportunistic strategies.
Portfolio Companies
12
Website
cormorantcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Alumis Inc | Mar 2024 | Series C | - |
| Freenome | Feb 2024 | VC Round | - |
| BioAge Labs | Feb 2024 | Series D | - |
| Supira Medical | Mar 2025 | Series E | - |
| TriveniBio | Oct 2023 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cormorant Capital based?
Cormorant Capital is headquartered in New York City, New York, United States.
When was Cormorant Capital founded?
Founding year information for Cormorant Capital is not publicly available.
How many portfolio companies does Cormorant Capital have?
Cormorant Capital has 12 portfolio companies in Caplight's dataset.
What are some companies in Cormorant Capital's portfolio?
Portfolio companies visible on Caplight include Alumis Inc, Freenome, BioAge Labs, Supira Medical, TriveniBio.
What was Cormorant Capital's most recent investment shown here?
Cormorant Capital's most recent investment in this portfolio sample was in Supira Medical in 2025.
What sectors does Cormorant Capital focus on?
Cormorant Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Cormorant Capital focus on?
Cormorant Capital typically invests at the MultiStage stage.
What is Cormorant Capital's AUM?
Cormorant Capital's assets under management are estimated between $1.0B and $10.0B.